Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Didier Bouscary, Laury Poulain et al.|Blood|2015Cited by 383
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Nathalie Jacque et al.|Blood|2013Cited by 286
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S. Green, Jérôme Tamburini, Nicolas Chapuis et al.|Blood|2010Cited by 196
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesisHana Forejtníková, Frédèrique Verdier, Maud Vieillevoye et al.|Blood|2010Cited by 149
Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 ImmunotherapySarah Porte, Bruno Martin, Alexandra Audemard‐Verger et al.|Cancer Immunology Research|2024Cited by 11